BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pancreas
,
Metabolism of nitric oxide
,
Cisplatin
,
rs7903146
,
FXYD4
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
microgynon
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Nonenveloped Avian Reoviruses Released with Small Extracellular Vesicles Are Highly Infectious.
A Drug-Drug Interaction Study to Investigate the Effect of Nintedanib on the Pharmacokinetics of Mic…
Evaluation of Pathogenicity and Antigenicity of Avian Reoviruses and Disease Control Through Vaccina…
Avian Reoviruses in Poultry Farms from Brazil.
Progress in research on the molecular biological detection techniques of avian encephalomyelitis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Cladribine Tablets on the PK of Microgynon®
Pharmacokinetic Effect of Evotaz/Microgynon Co-administration
Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon
Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women
Drug-drug Interaction of BI 201335 and Microgynon
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ